Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Transcriptomic model-based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma.

Zhang ZL, Zhao LJ, Xu L, Chai L, Wang F, Xu YP, Zhou SH, Fu Y.

Oncol Lett. 2019 Jun;17(6):5536-5544. doi: 10.3892/ol.2019.10213. Epub 2019 Apr 4.

2.

Seven LncRNA-mRNA based risk score predicts the survival of head and neck squamous cell carcinoma.

Zhang ZL, Zhao LJ, Chai L, Zhou SH, Wang F, Wei Y, Xu YP, Zhao P.

Sci Rep. 2017 Mar 22;7(1):309. doi: 10.1038/s41598-017-00252-2.

3.

A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.

Cao W, Liu JN, Liu Z, Wang X, Han ZG, Ji T, Chen WT, Zou X.

Oral Oncol. 2017 Feb;65:94-101. doi: 10.1016/j.oraloncology.2016.12.017. Epub 2017 Jan 3.

PMID:
28109476
4.

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).

Wang P, Jin M, Sun CH, Yang L, Li YS, Wang X, Sun YN, Tian LL, Liu M.

Biosci Rep. 2018 Nov 20;38(6). pii: BSR20181528. doi: 10.1042/BSR20181528. Print 2018 Dec 21.

5.

Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.

Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K.

World J Gastroenterol. 2019 Jan 14;25(2):220-232. doi: 10.3748/wjg.v25.i2.220.

6.

A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.

Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY.

BMC Cancer. 2018 Feb 6;18(1):147. doi: 10.1186/s12885-018-4058-6.

7.
8.

Transcriptomic analysis reveals key lncRNAs associated with ribosomal biogenesis and epidermis differentiation in head and neck squamous cell carcinoma.

Guo YZ, Sun HH, Wang XT, Wang MT.

J Zhejiang Univ Sci B. 2018 Sept.;19(9):674-688. doi: 10.1631/jzus.B1700319.

9.

A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.

Mao X, Qin X, Li L, Zhou J, Zhou M, Li X, Xu Y, Yuan L, Liu QN, Xing H.

Gynecol Oncol. 2018 Apr;149(1):181-187. doi: 10.1016/j.ygyno.2017.12.011. Epub 2018 Mar 8.

PMID:
29525275
10.

An 11-lncRNA expression could be potential prognostic biomarkers in head and neck squamous cell carcinoma.

Xu Q, Yin H, Ao H, Leng X, Liu M, Liu Y, Ma J, Wang X.

J Cell Biochem. 2019 May 29. doi: 10.1002/jcb.29113. [Epub ahead of print]

PMID:
31144382
11.

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.

Zhao QJ, Zhang J, Xu L, Liu FF.

World J Gastroenterol. 2018 Aug 14;24(30):3426-3439. doi: 10.3748/wjg.v24.i30.3426.

12.

Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.

Diao P, Song Y, Ge H, Wu Y, Li J, Zhang W, Wang Y, Cheng J.

J Cell Biochem. 2019 Jun;120(6):10010-10020. doi: 10.1002/jcb.28284. Epub 2018 Dec 11.

PMID:
30548328
13.

A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.

Zhou M, Guo M, He D, Wang X, Cui Y, Yang H, Hao D, Sun J.

J Transl Med. 2015 Jul 17;13:231. doi: 10.1186/s12967-015-0556-3.

14.

HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.

Yin X, Yang W, Xie J, Wei Z, Tang C, Song C, Wang Y, Cai Y, Xu W, Han W.

Biomed Res Int. 2019 Mar 26;2019:5450617. doi: 10.1155/2019/5450617. eCollection 2019.

15.

Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.

Sui J, Xu SY, Han J, Yang SR, Li CY, Yin LH, Pu YP, Liang GY.

Oncotarget. 2017 Jul 27;8(39):65997-66018. doi: 10.18632/oncotarget.19627. eCollection 2017 Sep 12.

16.

The discovery of a novel eight-mRNA-lncRNA signature predicting survival of hepatocellular carcinoma patients.

Shi YM, Li YY, Lin JY, Zheng L, Zhu YM, Huang J.

J Cell Biochem. 2018 Nov 28. doi: 10.1002/jcb.28028. [Epub ahead of print]

PMID:
30485492
17.

Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.

Zhang B, Wang H, Guo Z, Zhang X.

J Cell Physiol. 2019 Aug;234(10):18781-18791. doi: 10.1002/jcp.28517. Epub 2019 Mar 29.

PMID:
30927266
18.

Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.

Cui L, Cheng S, Liu X, Messadi D, Yang Y, Hu S.

Oncotarget. 2016 Dec 13;7(50):82634-82647. doi: 10.18632/oncotarget.13020.

19.
20.

Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.

Zhou M, Zhao H, Wang Z, Cheng L, Yang L, Shi H, Yang H, Sun J.

J Exp Clin Cancer Res. 2015 Sep 11;34:102. doi: 10.1186/s13046-015-0219-5.

Supplemental Content

Support Center